Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Cortex. 2019 Sep 19;121:147–168. doi: 10.1016/j.cortex.2019.08.016

Figure 6.

Figure 6.

Average activation across all ROIs at pre- and post-treatment in responders (blue dots/dashed line) and non-responders (red dots/solid line). Responders had a significant increase in activation (p < .001), while nonresponders showed no significant change. For reference, average activation for healthy controls (HC) is plotted as a dotted gray line.

N: nonresponders; R: responders